[1]
F. Brockmeyer and R. Manetsch, “Progress in the Optimization of 4(1H)-Quinolone Derivatives as Antimalarials Targeting the Erythrocytic, the Exoerythrocytic and the Transmitting Stages of the Malaria Parasite”, Chimia, vol. 71, no. 4, p. 213, Apr. 2017.